The U.S. FDA is proposing to remove oral phenylephrine from over-the-counter nasal congestion medications due to ineffectiveness. They found that old data used to approve it may have been flawed, and newer studies show it doesn’t provide real-world symptom relief. Phenylephrine works by narrowing blood vessels in the nasal passages. This proposal targets only oral phenylephrine, not nasal sprays. The FDA is seeking public comment on the proposal, and if finalized, manufacturers will need to reformulate their products. Consumers are advised to be aware of this potential change, read labels, and consult with healthcare providers for alternative nasal congestion treatments.
Source link
Did phenylephrine just get banned?| Medical News Bulletin
